WW, formerly Weight Watchers, introduces program targeting stress, sleep as virus spikes
The myWW+ program builds upon Weight Watchers' new customizable myWW program which was launched last November.
EU seeks Moderna COVID vaccine deal at below $25 per dose
The European Commission wants to reach a deal with Moderna Inc. for the supply of millions of doses of its COVID-19 vaccine candidate for a price below $25 per dose
Moderna CEO cheers coronavirus vaccine safety as 'gamechanger,' with 20M doses available by end of year
Moderna CEO Stephane Bancel said his company's coronavirus vaccine has demonstrated a "gamechanger" safety record in ongoing studies, along with 94.5% effectiveness.
Moderna says its vaccine is 94.5% effective in preventing COVID-19
Together with Pfizer Inc's vaccine, also shown to be more than 90% effective, and pending more safety data and regulatory review, the United States could have two vaccines authorized for emergency use in December with as many as 60 million doses of vaccine available by the year's end.
Biden advisers to meet with vaccine firms this week
“We’re going to start those consultations this week,” Biden’s chief of staff, Ron Klain told NBC's 'Meet the Press', citing Pfizer and other pharmaceutical companies
Pfizer-BioNTech vaccine creator says life could return to ‘normal’ next winter
One of the scientists behind Pfizer-BioNTech’s promising COVID-19 vaccine candidate says the potential cure could return the world to “normal” by next winter.
Insurance and you -- why open enrollment is not something to ignore
During open enrollment, your employer is offering you the chance to make potentially critical adjustments to your health insurance.
Coronavirus lockdowns not necessary, health secretary Alex Azar says
Health and Human Services Secretary Alex Azar on Friday rejected the notion of another shutdown in the U.S. to curb a spike in COVID-19 cases and hospitalizations across the country.
7 SeaDream cruise passengers test positive for coronavirus, 1 hospitalized
Although SeaDream says it operated successfully earlier this year in Norway, the shipboard COVID-19 outbreak has renewed concerns over the safety of ocean travel during the pandemic.
Biden has room on health care, though limited by Congress
Biden's proposals for a public health insurance option and empowering Medicare to negotiate prescription drug prices seem out of reach
North Dakota allows infected nurses to keep working
The North Dakota Nurses Association says it doesn’t support a move to allow health care workers who have tested positive for the coronavirus but don’t have symptoms to remain on the job.
Lemonade CEO: Expanding from rental insurance to pet, life insurance
Daniel Schreiber on Lemonade, insurance
Pfizer-BioNTech coronavirus vaccine expected to protect patients for a year: CEO
The Pfizer-BioNTech coronavirus vaccine could protect patients from the virus for a year, BioNTech CEO Ugur Sahin told "Mornings with Maria" on Thursday.
Ticketmaster exploring negative COVID-19 test or vaccination to attend concerts
The plan, which is still being ironed out, will utilize three separate components, including the California-based company’s digital ticketing app.
Biden COVID-19 adviser suggests potential lockdown lasting over a month
One of President-elect Joe Biden’s coronavirus advisers floated the idea of a nationwide coronavirus lockdown in an effort to rein in the illness and rejuvenate the economy as new cases climb once again.
Military veterans have it best in these US cities in 2020: report
On Monday, WalletHub published a report that found the best cities for military veterans to live.
Moderna may seek FDA authorization for COVID-19 vaccine in December
The company may have to wait for two-month follow-up safety data to apply for U.S. emergency use authorization, even after reporting positive interim data on the vaccine's effectiveness.
Pfizer CEO unloads $5.6M of stock as coronavirus vaccine hopes send shares soaring
Albert Bourla sold 132,508 Pfizer shares at a price of $41.94 apiece through a scheduled Rule 10b5-1 trading plan adopted on Aug. 19, one day after the company announced positive results from a Phase 1 study.
Russia says its Sputnik V COVID-19 vaccine is 92% effective
The initial results are only the second to be published from a late-stage human trial in the global effort to produce vaccines
COVID-19 vaccine by the numbers: U.S., EU lead orders
Pfizer expects to supply 50 million doses in 2020 and manufacture up to 1.3 billion doses in 2021.



















